167 related articles for article (PubMed ID: 8957084)
1. Activation of JNK/SAPK pathway is not directly inhibitory for cell cycle progression in NIH3T3 cells.
Shu J; Hitomi M; Stacey D
Oncogene; 1996 Dec; 13(11):2421-30. PubMed ID: 8957084
[TBL] [Abstract][Full Text] [Related]
2. c-myc-enhanced S phase entry in keratinocytes is associated with positive and negative effects on cyclin-dependent kinases.
Alexandrow MG; Moses HL
J Cell Biochem; 1998 Sep; 70(4):528-42. PubMed ID: 9712150
[TBL] [Abstract][Full Text] [Related]
3. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.
Santoni-Rugiu E; Jensen MR; Thorgeirsson SS
Cancer Res; 1998 Jan; 58(1):123-34. PubMed ID: 9426068
[TBL] [Abstract][Full Text] [Related]
4. Mitogen activated protein kinase-dependent activation of c-Jun and c-Fos is required for neuronal differentiation but not for growth and stress response in PC12 cells.
Eriksson M; Taskinen M; Leppä S
J Cell Physiol; 2007 Feb; 210(2):538-48. PubMed ID: 17111371
[TBL] [Abstract][Full Text] [Related]
5. Cyclin E and c-Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblastoma family proteins.
Alevizopoulos K; Vlach J; Hennecke S; Amati B
EMBO J; 1997 Sep; 16(17):5322-33. PubMed ID: 9311992
[TBL] [Abstract][Full Text] [Related]
6. Active, phosphorylation-dependent MAP kinases, MAPK/ERK, SAPK/JNK and p38, and specific transcription factor substrates are differentially expressed following systemic administration of kainic acid to the adult rat.
Ferrer I; Blanco R; Carmona M; Puig B; Domínguez I; Viñals F
Acta Neuropathol; 2002 Apr; 103(4):391-407. PubMed ID: 11904760
[TBL] [Abstract][Full Text] [Related]
7. Oxidized LDL induces transcription factor activator protein-1 in rat mesangial cells.
Wu ZL; Wang YC; Zhou Q; Ge YQ; Lan Y
Cell Biochem Funct; 2003 Sep; 21(3):249-56. PubMed ID: 12910478
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of cyclin A gene expression upon genotoxic stress correlates with reduced binding of free E2F to the promoter.
Spitkovsky D; Schulze A; Boye B; Jansen-Dürr P
Cell Growth Differ; 1997 Jun; 8(6):699-710. PubMed ID: 9186003
[TBL] [Abstract][Full Text] [Related]
9. The cyclin-dependent kinase inhibitor (CDKI) flavopiridol disrupts phorbol 12-myristate 13-acetate-induced differentiation and CDKI expression while enhancing apoptosis in human myeloid leukemia cells.
Cartee L; Wang Z; Decker RH; Chellappan SP; Fusaro G; Hirsch KG; Sankala HM; Dent P; Grant S
Cancer Res; 2001 Mar; 61(6):2583-91. PubMed ID: 11289135
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional induction of cyclooxygenase-2 gene by okadaic acid inhibition of phosphatase activity in human chondrocytes: co-stimulation of AP-1 and CRE nuclear binding proteins.
Miller C; Zhang M; He Y; Zhao J; Pelletier JP; Martel-Pelletier J; Di Battista JA
J Cell Biochem; 1998 Jun; 69(4):392-413. PubMed ID: 9620167
[TBL] [Abstract][Full Text] [Related]
11. [Effect of anisomycin on activation of early response genes c-fos, c-jun, Egr-1 in cells transformed by E1A and cHa-ras oncogenes].
Kukushkin AN; Svetlikova SB; Pospelov VA
Mol Biol (Mosk); 2005; 39(1):80-8. PubMed ID: 15773551
[TBL] [Abstract][Full Text] [Related]
12. K-ras modulates the cell cycle via both positive and negative regulatory pathways.
Fan J; Bertino JR
Oncogene; 1997 May; 14(21):2595-607. PubMed ID: 9191059
[TBL] [Abstract][Full Text] [Related]
13. An E2F dominant negative mutant blocks E1A induced cell cycle progression.
Dobrowolski SF; Stacey DW; Harter ML; Stine JT; Hiebert SW
Oncogene; 1994 Sep; 9(9):2605-12. PubMed ID: 8058324
[TBL] [Abstract][Full Text] [Related]
14. DNA replication arrest in response to genotoxic stress provokes early activation of stress-activated protein kinases (SAPK/JNK).
Damrot J; Helbig L; Roos WP; Barrantes SQ; Kaina B; Fritz G
J Mol Biol; 2009 Feb; 385(5):1409-21. PubMed ID: 19109974
[TBL] [Abstract][Full Text] [Related]
15. 17 beta-Estradiol overcomes a G1 block induced by HMG-CoA reductase inhibitors and fosters cell cycle progression without inducing ERK-1 and -2 MAP kinases activation.
Bonapace IM; Addeo R; Altucci L; Cicatiello L; Bifulco M; Laezza C; Salzano S; Sica V; Bresciani F; Weisz A
Oncogene; 1996 Feb; 12(4):753-63. PubMed ID: 8632897
[TBL] [Abstract][Full Text] [Related]
16. Cell cycle progression proteins (cyclins), oncogene expression, and signal transduction during the proliferative response of human hepatocytes to hepatocyte growth factor.
Gómez-Lechón MJ; Guillén I; Ponsoda X; Fabra R; Trullenque R; Nakamura T; Castell JV
Hepatology; 1996 May; 23(5):1012-9. PubMed ID: 8621126
[TBL] [Abstract][Full Text] [Related]
17. A non-enzymatic p21 protein inhibitor of stress-activated protein kinases.
Shim J; Lee H; Park J; Kim H; Choi EJ
Nature; 1996 Jun; 381(6585):804-6. PubMed ID: 8657286
[TBL] [Abstract][Full Text] [Related]
18. Protein synthesis inhibitors reveal differential regulation of mitogen-activated protein kinase and stress-activated protein kinase pathways that converge on Elk-1.
Zinck R; Cahill MA; Kracht M; Sachsenmaier C; Hipskind RA; Nordheim A
Mol Cell Biol; 1995 Sep; 15(9):4930-8. PubMed ID: 7651411
[TBL] [Abstract][Full Text] [Related]
19. Induction of GLUT1 mRNA in response to azide and inhibition of protein synthesis.
Behrooz A; Ismail-Beigi F
Mol Cell Biochem; 1998 Oct; 187(1-2):33-40. PubMed ID: 9788740
[TBL] [Abstract][Full Text] [Related]
20. The mitogenic effect of parathyroid hormone is associated with E2F-dependent activation of cyclin-dependent kinase 1 (cdc2) in osteoblast precursors.
Onishi T; Zhang W; Cao X; Hruska K
J Bone Miner Res; 1997 Oct; 12(10):1596-605. PubMed ID: 9333120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
